Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05691504 |
| Title | Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute | RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
| Johns Hopkins University/Sidney Kimmel Cancer Center | RECRUITING | Baltimore | Maryland | 21287 | United States | Details |
| National Cancer Institute Developmental Therapeutics Clinic | RECRUITING | Bethesda | Maryland | 20892 | United States | Details |
| National Institutes of Health Clinical Center | SUSPENDED | Bethesda | Maryland | 20892 | United States | Details |
| Dana-Farber - Harvard Cancer Center LAO | RECRUITING | Boston | Massachusetts | 02115 | United States | Details |
| Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |